Clinical Trial Update: A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

This clinical trial update reports the Phase 1 safety and pharmacokinetics evaluation of PRO283698 in patients with rheumatoid arthritis, with the study having …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• PRO283698

Snippet

Sponsor: Genentech, Inc. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED